Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126517451 | 12651745 | 1 | I | 20160803 | 20160815 | 20160815 | EXP | DK-PFIZER INC-2016374889 | PFIZER | KRABBE, S.. TOXIC EPIDERMAL NECROLYSIS-LIKE LESIONS AND SYSTEMIC LUPUS ERYTHEMATOSUS POSSIBLY TRIGGERED BY SULFASALAZINE. CASE REPORTS IN RHEUMATOLOGY PRINT. 2016;2016 | 48.00 | YR | M | Y | 0.00000 | 20160815 | OT | DK | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126517451 | 12651745 | 1 | PS | SULFASALAZINE. | SULFASALAZINE | 1 | UNK | 7073 | |||||||||||
| 126517451 | 12651745 | 2 | C | PREDNISOLONE. | PREDNISOLONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126517451 | 12651745 | 1 | Spinal osteoarthritis |
| 126517451 | 12651745 | 2 | Spinal osteoarthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126517451 | 12651745 | OT |
| 126517451 | 12651745 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126517451 | 12651745 | Systemic lupus erythematosus | |
| 126517451 | 12651745 | Toxic epidermal necrolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |